NCT04464122 2025-04-03
REBORN
University of Roma La Sapienza
Recruiting
Clinical Trials
11 trialsNCT06855095 2025-03-03
ATSA
The Netherlands Cancer Institute
Phase 2/3 Recruiting
NCT02795858 2025-02-19
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Dana-Farber Cancer Institute
Phase 2 Completed
NCT05701241 2024-06-14
SAUNA
University Hospital, Antwerp
Phase 4 Recruiting
NCT04557137 2020-09-21
Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia
University of Aarhus
Unknown
NCT04129255 2020-09-10
CSMS99
National Cancer Institute, Naples
Phase 2 Completed
NCT01755182 2016-05-06
LOTUS
National Cancer Institute, Naples
Phase 3 Terminated
NCT02631616 2015-12-16
Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET
Hadassah Medical Organization
Phase 1 Unknown
NCT01053390 2013-12-20
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 3 Completed
NCT01914692 2013-08-02
Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection
First Affiliated Hospital, Sun Yat-Sen University
Phase 4 Completed
NCT00386984 2006-10-12
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma
University Hospital Freiburg
Phase 3 Completed